Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Coherus BioSciences
Coherus BioSciences
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Loqtorzi
Toripalimab
2023-10-27
Nasopharyngeal carcinoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toripalimab
neuroendocrine tumors
,
transplantation
,
liver transplantation
,
brain neoplasms
,
prostatic neoplasms
,
lymphoproliferative disorders
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
colorectal neoplasms
,
pancreatic neoplasms
,
head and neck neoplasms
,
kidney neoplasms
,
hypopharyngeal neoplasms
,
sarcoma
,
ovarian neoplasms
,
laryngeal neoplasms
,
oropharyngeal neoplasms
,
colonic neoplasms
,
large b-cell lymphoma diffuse
,
cutaneous malignant melanoma
,
endometrial neoplasms
,
epstein-barr virus infections
,
small cell carcinoma
,
skin neoplasms
,
thoracic neoplasms
,
microsatellite instability
,
thrombosis
,
induction chemotherapy
,
mouth neoplasms
,
salivary gland neoplasms
,
liposarcoma
,
malignant fibrous histiocytoma
,
invasive hydatidiform mole
,
gestational trophoblastic disease
,
gallbladder neoplasms
,
non-muscle invasive bladder neoplasms
,
tertiary lymphoid structures
,
lung diseases
,
glandular and epithelial neoplasms
,
thymus neoplasms
,
malignant mesothelioma
,
mesothelioma
,
follicular lymphoma
,
large-cell lymphoma anaplastic
,
hypertrophic pyloric stenosis
,
bile duct neoplasms
,
thyroid neoplasms
,
thyroid diseases
,
extranodal nk-t-cell lymphoma
,
nasopharyngeal diseases
,
pancreatic ductal carcinoma
,
digestive system neoplasms
,
peritoneal neoplasms
,
anus neoplasms
,
trophoblastic neoplasms
,
gastrointestinal microbiome
,
ampulla of vater cancer
,
kidney diseases
,
urogenital neoplasms
,
urologic diseases
,
male urogenital diseases
,
female urogenital diseases
,
urogenital diseases
,
ductal carcinoma
,
castration-resistant prostatic neoplasms
,
penile neoplasms
,
meningeal carcinomatosis
,
renal insufficiency
,
ureteral neoplasms
,
solitary kidney
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
klatskin tumor
,
extramammary paget disease
,
molecular targeted therapy
,
paranasal sinus neoplasms
,
leiomyosarcoma
,
anxiety disorders
,
depressive disorder
,
carcinoma in situ
,
papillomavirus infections
,
dermatofibrosarcoma
,
ablation techniques
,
carcinoma
,
neoplasms
,
nasopharyngeal carcinoma
,
non-small-cell lung carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
squamous cell carcinoma of head and neck
,
melanoma
,
lung neoplasms
,
triple negative breast neoplasms
,
renal cell carcinoma
,
stomach neoplasms
,
small cell lung carcinoma
,
recurrence
,
esophageal neoplasms
,
adenocarcinoma
,
transitional cell carcinoma
,
urinary bladder neoplasms
,
uterine cervical neoplasms
,
cholangiocarcinoma
,
neoplasm metastasis
,
immunotherapy
,
urologic neoplasms
,
neoadjuvant therapy
,
drug therapy
,
rectal neoplasms
,
squamous cell neoplasms
,
radiotherapy
,
chemoradiotherapy
,
lymphoma
,
pathologic complete response
,
neuroendocrine carcinoma
,
maintenance chemotherapy
,
hereditary nonpolyposis colorectal neoplasms
,
radiation
,
hodgkin disease
,
radiosurgery
,
nasopharyngeal neoplasms
,
breast neoplasms
,
biliary tract neoplasms
,
residual neoplasm
,
liver diseases
,
female genital neoplasms
,
abdominal neoplasms
,
transplantation chimera
,
acute kidney injury
,
catheter ablation
Zimberelimab
neoplasms
,
carcinoma
,
ovarian neoplasms
,
urinary bladder neoplasms
,
esophageal neoplasms
,
uterine cervical neoplasms
,
breast neoplasms
,
endometrial neoplasms
,
merkel cell carcinoma
,
non-hodgkin lymphoma
,
multiple myeloma
,
large b-cell lymphoma diffuse
,
recurrence
,
glioblastoma
,
head and neck neoplasms
,
mouth neoplasms
,
oropharyngeal neoplasms
,
pharyngeal neoplasms
,
laryngeal neoplasms
,
hypopharyngeal neoplasms
,
triple negative breast neoplasms
,
renal cell carcinoma
,
squamous cell carcinoma of head and neck
,
castration-resistant prostatic neoplasms
,
lung neoplasms
,
pancreatic neoplasms
,
melanoma
,
colorectal neoplasms
,
squamous cell carcinoma
,
cholangiocarcinoma
,
prostatic neoplasms
,
kidney neoplasms
,
rectal neoplasms
,
gastrointestinal diseases
,
adenosquamous carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
small cell carcinoma
,
pancreatic ductal carcinoma
,
bile duct neoplasms
,
biliary tract neoplasms
,
adenocarcinoma
,
non-small-cell lung carcinoma
,
stomach neoplasms
ETRUMADENANT
healthy volunteers/patients
,
ovarian neoplasms
,
carcinoma
,
squamous cell carcinoma of head and neck
,
triple negative breast neoplasms
,
renal cell carcinoma
,
breast neoplasms
,
endometrial neoplasms
,
urinary bladder neoplasms
,
melanoma
,
merkel cell carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma
,
mouth neoplasms
,
oropharyngeal neoplasms
,
pharyngeal neoplasms
,
laryngeal neoplasms
,
hypopharyngeal neoplasms
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
lung neoplasms
,
adenocarcinoma
,
pancreatic neoplasms
,
small cell carcinoma
,
rectal neoplasms
,
urologic neoplasms
,
neoplasms
,
transitional cell carcinoma
,
neoplasm metastasis
,
sarcoma
,
liposarcoma
,
pancreatic ductal carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use